All Stories

  1. Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework
  2. Challenges in the Development and Implementation of Point‐of‐Care Handheld qPCR Devices
  3. Preeclampsia Diagnostics and Therapeutics: Advances, Challenges, and Prospects in Nanoscale Exosome-Based Clinical Translation
  4. Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases
  5. Enhancing Electrochemical Biosensing of Circulating Nucleic Acids at the Electrode-Biomolecule-Electrolyte Interfaces
  6. Nanoarchitectonics of point-of-care diagnostics for sweat biomarkers analysis
  7. Clinically Boosting Cancer Molecular Targeted Radioligand Therapies with Innovative Nanomaterials
  8. Point-of-need mastitis pathogen biosensing in bovine milk: From academic sample preparation novelty to industry prototype field testing
  9. Cancer‐on‐Chip and Integrative Tumor Microenvironment Sensor Technologies for Progressing Precision Radiotherapy
  10. Design and Analytical Evaluation of a Rapid Plasma Screening Assay for Circulating Human Papillomavirus DNA via Thermostable Enzyme Chemistries
  11. Multifunctional Hybrid Nanozymes for Magnetic Enrichment and Bioelectrocatalytic Sensing of Circulating Tumor RNA during Minimal Residual Disease Monitoring
  12. Point-of-Need Automated Bovine Milk Sample Preparation and Molecular Biosensing of Bacterial Mastitis Pathogens
  13. Nanophotonic immunoarray with electrochemically roughened surfaces for handheld detection of secreted PD-L1 to predict immuno-oncology efficacy
  14. Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing?
  15. Streptavidin-Modified Iron Oxide Hybrid Nanozymes for Magnetic Enrichment and Bioelectrocatalytic Sensing of Circulating Tumor RNA
  16. Tetraplex Immunophenotyping of Cell Surface Proteomes via Synthesized Plasmonic Nanotags and Portable Raman Spectroscopy
  17. Harnessing Gene Fusion-Derived Neoantigens for ‘Cold’ Breast and Prostate Tumor Immunotherapy
  18. Molecular locker probe enrichment of gene fusion variants from matched patient liquid biopsy specimens for magneto-bioelectrocatalytic nanosensing
  19. Progressing Antimicrobial Resistance Sensing Technologies across Human, Animal, and Environmental Health Domains
  20. Bioengineered Polymer Nanobeads for Isolation and Electrochemical Detection of Cancer Biomarkers
  21. Magnetic nanomaterial–based electrochemical biosensors for the detection of diverse circulating cancer biomarkers
  22. Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges
  23. Simultaneous BRAFV600E Protein and DNA Aberration Detection in Circulating Melanoma Cells Using an Integrated Multimolecular Sensor
  24. Nucleic Acid Hybridization‐Based Noise Suppression for Ultraselective Multiplexed Amplification of Mutant Variants
  25. Direct Enhanced Detection of Multiple Circulating Tumor DNA Variants in Unprocessed Plasma by Magnetic-Assisted Bioelectrocatalytic Cycling
  26. Multiomics: The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies (Adv. Funct. Mater. 37/2020)
  27. Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies
  28. Phosphoprotein Biosensors for Monitoring Pathological Protein Structural Changes
  29. The Role of Circulating Tumor DNA Testing in Breast Cancer Liquid Biopsies: Getting Ready for Prime Time
  30. The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies
  31. Native MicroRNA Targets Trigger Self‐Assembly of Nanozyme‐Patterned Hollowed Nanocuboids with Optimal Interparticle Gaps for Plasmonic‐Activated Cancer Detection
  32. Engineering State‐of‐the‐Art Plasmonic Nanomaterials for SERS‐Based Clinical Liquid Biopsy Applications
  33. Watching SERS glow for multiplex biomolecular analysis in the clinic: A review
  34. Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
  35. An integrated multi-molecular sensor for simultaneous BRAFV600E protein and DNA single point mutation detection in circulating tumour cells
  36. Single droplet detection of immune checkpoints on a multiplexed electrohydrodynamic biosensor
  37. Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics
  38. A Sample-to-Targeted Gene Analysis Biochip for Nanofluidic Manipulation of Solid-Phase Circulating Tumor Nucleic Acid Amplification in Liquid Biopsies
  39. “Mix-to-Go” Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction
  40. Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction
  41. Adjustable Fluidic Nanomixing: Amplification-Free Multi-RNA-Type Profiling for Cancer Risk Stratification via Alternating Current Electrohydrodynamic Nanomixing (Small 17/2018)
  42. Amplification-Free Multi-RNA-Type Profiling for Cancer Risk Stratification via Alternating Current Electrohydrodynamic Nanomixing
  43. An exosomal- and interfacial-biosensing based strategy for remote monitoring of aberrantly phosphorylated proteins in lung cancer cells
  44. Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay
  45. Interfacial Biosensing: Direct Biosensing of Biomolecules at the Bare Metal Interface
  46. DNA-directed assembly of copper nanoblocks with inbuilt fluorescent and electrochemical properties: Application in simultaneous amplification-free analysis of multiple RNA species
  47. High-speed biosensing strategy for non-invasive profiling of multiple cancer fusion genes in urine
  48. A nanoplasmonic label-free surface-enhanced Raman scattering strategy for non-invasive cancer genetic subtyping in patient samples
  49. Enabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop
  50. Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine
  51. Rapid and Sensitive Fusion Gene Detection in Prostate Cancer Urinary Specimens by Label-Free Surface-Enhanced Raman Scattering
  52. A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2:ERG gene fusion RNA
  53. Amplification-Free Detection of Gene Fusions in Prostate Cancer Urinary Samples Using mRNA–Gold Affinity Interactions
  54. Poly(A) Extensions of miRNAs for Amplification-Free Electrochemical Detection on Screen-Printed Gold Electrodes
  55. Colorimetric TMPRSS2-ERG Gene Fusion Detection in Prostate Cancer Urinary Samples via Recombinase Polymerase Amplification
  56. DNA–bare gold affinity interactions: mechanism and applications in biosensing
  57. Microdevices for detecting locus-specific DNA methylation at CpG resolution
  58. eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes
  59. μ-eLCR: a microfabricated device for electrochemical detection of DNA base changes in breast cancer cell lines
  60. Advancing Gene Fusion Detection towards Personalized Cancer Nanodiagnostics